Health

There’s enough to worry about during a pregnancy, even without a pandemic. As the vaccine rollout continues, there’s still concern over its impact on pregnancy. Covid-19 has added an entirely new layer of health anxiety for anyone expecting a child. That’s why one of the biggest questions on many pregnant women’s minds is if the

A new ensemble forecast published Wednesday by the Centers for Disease Control and Prevention suggests the daily Covid-19 death rate will slow in the coming weeks — good news following more than a month of declining case and hospitalization numbers. But now is no time to let up on safety measures — for several reasons

A majority of US adults — nearly six in 10 — say that K-12 schools that are not currently open for in-person learning should wait until all teachers receive the Covid-19 vaccine before they reopen, according to a new survey. Some 59% of adults said schools should wait for teachers to be vaccinated, compared with

Vaccine makers Pfizer and Moderna are trying to get out ahead of some of the new coronavirus variants that are causing concern around the world. Although there’s no evidence people immunized with either vaccine have less protection against the variants, both companies said they have started looking at ways to account for evolving mutations. Especially

Coronavirus infections across the US are still on the way down, and more Americans are getting vaccinated — but variants could cause complications soon. Several experts predicted the highly contagious B.1.1.7 variant first detected in the UK is likely to fuel another surge of cases in just a matter of weeks. “It could result in

The receptionist at the doctor’s office asks a question from behind her double mask and face guard on the opposite side of a large, plastic partition. “Excuse me, what was that again?” It’s a phrase I repeat a lot these days. Distorted by masks and myriad sound barriers, sounds in the world around me have

The US is one step closer to having a third Covid-19 vaccine and it can’t come soon enough. With people clamoring for a shot, it was welcome news that the US Food and Drug Administration’s analysis Johnson & Johnson’s trial data showed its vaccine is safe and effective. Here’s what that could mean for you.

In an analysis released Wednesday, the US Food and Drug Administration said the Johnson & Johnson Covid-19 vaccine has met the requirements for emergency use authorization — another step toward the authorization of a third shot for the United States. The efficacy of the Johnson & Johnson vaccine against moderate to severe/critical Covid-19 across all

Johnson & Johnson says that it has 4 million doses of its Covid-19 vaccine ready to ship “immediately” once it receives emergency use authorization, which could happen this week. But as the decision nears, it’s unclear when or where those doses will be delivered. During a briefing on Wednesday, White House Covid coordinator Jeff Zients

In an analysis released Wednesday, the US Food and Drug Administration said the Johnson & Johnson Covid-19 vaccine has met the requirements for emergency use authorization. The efficacy of the Johnson & Johnson vaccine against moderate to severe/critical Covid-19 across all geographic areas was 66.9% at least 14 days after the single dose vaccination and

Coronavirus infections across the US are still on the way down, and more Americans are getting vaccinated — but variants could cause complications soon. Several experts predicted Tuesday the highly contagious B.1.1.7 variant first detected in the UK is likely to fuel another surge of cases in just a matter of weeks. “It could result

The United States can expect to see a total of 240 million doses of Covid-19 vaccine by the end of March, drug companies told a House subcommittee Tuesday. Pfizer and Moderna — the two companies with Covid-19 vaccines authorized for emergency use in the United States — have pledged to make a combined total of